Cronos Group Inc.
CRON Nasdaq· Medicinal Chemicals & Botanical Products
Last close · Oct 26, 2026
$3.31
KIRA · Stoqly’s AI analyst, in plain words
- Cronos Group Inc. had $147M of revenue in fiscal 2025, up 24.6% on the year before. Over five years, revenue changed +25.7% a year on average.
- Its operating margin was −11.9%, up 53.2 pts: of every 100 in sales, about −12 is left after running the business.
- Cronos Group Inc. lost $9.4M in fiscal 2025.
- Free cash flow was $0.1M in fiscal 2025, 0.1% of revenue.
- Cronos Group Inc. returned $9.7M to shareholders in fiscal 2025, 6,538% of free cash flow. The diluted share count fell 0.5%.
Market cap
$1.2B
P/E
17.4x
Revenue
$147M
Net income
−$9.4M
Free cash flow
$0.1M
Operating margin
−11.9%
Cronos Group Inc. in 30 seconds · fiscal 2025
Are sales growing?
+24.6%
Yes. Sales grew 24.6% last year.
Does it make a profit?
−6.4%
No. It lost money last year.
Does profit turn into cash?
0.1%
Partly. 0.1% of sales ends up as free cash.
How healthy are the accounts?
6 / 8
Mixed. It passes 6 of 8 health tests.
How is the share priced?
17.4x
One share costs 17.4 times its yearly profit per share.
What Cronos Group Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 26, 2026
- Legal name
- Cronos Group Inc.
- CIK
- 0001656472
Cronos Group Inc. · CRON
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $64.6M | $86.7M | $87.2M | $118M | $147M |
| Revenue growth | 38.2% | 34.4% | 0.6% | 34.8% | 24.6% |
| Gross margin | −27.3% | 17.8% | 13.7% | 21.4% | 42.8% |
| Operating margin | −452.2% | −128.4% | −97.2% | −65.1% | −11.9% |
| Net income | −$396M | −$169M | −$74.0M | $41.1M | −$9.4M |
| Net margin | −613.5% | −194.5% | −84.8% | 34.9% | −6.4% |
| Diluted EPS | −$1.07 | −$0.45 | −$0.19 | $0.11 | −$0.02 |
| Cash | |||||
| Cash from operations | −$154M | −$88.9M | −$42.8M | $18.8M | $25.9M |
| Capital expenditure | $11.1M | $3.5M | $2.5M | $12.4M | $25.7M |
| Free cash flow | −$165M | −$92.4M | −$45.3M | $6.4M | $0.1M |
| FCF margin | −255.2% | −106.5% | −52.0% | 5.5% | 0.1% |
| Share buybacks | — | — | $0.0M | $0.0M | $9.7M |
| Share count change | 5.4% | 1.8% | 1.1% | 1.2% | −0.5% |
| Debt and strength | |||||
| Cash and short-term investments | $1.0B | $878M | $862M | $859M | $832M |
| Shareholders' equity | $1.3B | $1.1B | $1.1B | $1.1B | $1.1B |
| Current ratio | 19.9x | 14.1x | 22.5x | 18.8x | 19.6x |
| Interest coverage | −10,813.7x | −8,571.4x | — | — | — |
| Returns and quality | |||||
| Return on equity | −26.0% | −13.6% | −6.6% | 3.8% | −0.9% |
| Return on tangible equity | −30.1% | −15.1% | −6.9% | 4.2% | −0.9% |
| Piotroski F-score | 4 | 4 | 4 | 5 | 6 |
| Altman Z'' | 27.1 | 22.2 | 32.0 | 26.0 | 27.2 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cronos Group Inc. · CRON
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $3.31 a share, the company is worth $1.2B: 17.4 times its earnings of the last four quarters.
Source: SEC EDGAR XBRL filings (CIK 0001656472). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.